Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000930413-18-002054
Filing Date
2018-06-20
Accepted
2018-06-20 16:14:42
Documents
1

Document Format Files

Seq Description Document Type Size
1 c91420_sc13da.htm SC 13D/A 97026
  Complete submission text file 0000930413-18-002054.txt   98543
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Subject) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-44055 | Film No.: 18909498
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 165 MASON STREET, 3RD FLOOR GREENWICH CT 06830
Business Address 165 MASON STREET, 3RD FLOOR GREENWICH CT 06830 203 971-3300
GREAT POINT PARTNERS LLC (Filed by) CIK: 0001281446 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A